News
Zevra Therapeutics Presents New Data On Long-Term Safety And Efficacy Of Arimoclomol As Treatment For Niemann-Pick Disease Type C At SIMD 45th Annual Meeting
15 Apr 24
News
HC Wainwright & Co. Reiterates Buy on Zevra Therapeutics, Maintains $15 Price Target
3 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Zevra Therapeutics: Q4 Earnings Insights
28 Mar 24
Earnings
Zevra Therapeutics Q4 2023 GAAP EPS $(0.40) Misses $(0.27) Estimate, Sales $13.217M Beat $11.738M Estimate
28 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For March 28, 2024
28 Mar 24
Earnings
Earnings Outlook For Zevra Therapeutics
27 Mar 24
Earnings
Zevra Therapeutics Reports Data From Phase 2 Clinical Trial Of KP1077 For Idiopathic Hypersomnia; Says KP1077 Demonstrates Clinically Meaningful Benefits For Key IH Symptoms
26 Mar 24
News
William Blair Initiates Coverage On Zevra Therapeutics with Outperform Rating
12 Mar 24
News, Initiation, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Zevra Therapeutics, Maintains $15 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Zevra Therapeutics Says FDA Has Extended Review Period For New Drug Application For Arimoclomol As Treatment For Niemann-Pick Disease Type C
4 Mar 24
News, FDA
Press releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
24 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
20 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
16 Apr 24
News, Legal, Press Releases
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
15 Apr 24
News, Health Care, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
12 Apr 24
Press Releases
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
10 Apr 24
News, Financing, Press Releases
Attention Zevra Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
8 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
8 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
4 Apr 24
Press Releases
ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm
3 Apr 24
News, Legal, Press Releases
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
2 Apr 24
News, Legal, Press Releases
Investigation Into Zevra Therapeutics, Inc. (ZVRA) Announced by Holzer & Holzer, LLC
2 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
1 Apr 24
News, Legal, Press Releases
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
28 Mar 24
Earnings, News, Health Care, Press Releases
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
26 Mar 24
Health Care, Press Releases, General
Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
25 Mar 24
News, Press Releases
Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
18 Mar 24
News, Press Releases
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
4 Mar 24
Health Care, Press Releases
Zevra Therapeutics to Participate at Upcoming Investor Conferences
28 Feb 24
News, Press Releases
Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
6 Feb 24
News, Press Releases